Who Buys Levothyroxine from India — 235 Importers Behind a $77.7M Market

The 235 buyers of Levothyroxine from India can be categorized into several segments:

1. Distributors: Entities that purchase Levothyroxine in bulk to supply to various healthcare providers. For instance, EVERSANA LIFE SCIENCES SERVICES, LLC in the United States, with total imports amounting to $8.93 million, operates as a distributor, facilitating the distribution of pharmaceuticals across multiple channels.

2. Contract Manufacturers: Companies that import Levothyroxine as an active pharmaceutical ingredient (API) for formulation and packaging. WOCKHARDT UK LIMITED in the United Kingdom, importing $5.92 million worth of Levothyroxine, exemplifies this segment, utilizing the API for their pharmaceutical products.

3. Retail Chains: Large pharmacy chains that import Levothyroxine to stock their outlets. MACLEODS PHARMA USA, INC, the top importer with $21.62 million in imports, likely distributes the medication through its extensive retail network.

4. Government Procurement Agencies: Organizations responsible for acquiring medications for public health programs. While specific agencies are not listed among the top buyers, countries like Peru and Chile, with significant import values, may involve government tenders in their procurement processes.

5. Re-exporters: Companies that import Levothyroxine for the purpose of exporting to other markets. ALEMBIC PHARMACEUTICALS SPA in Chile, with imports totaling $1.65 million, may engage in such activities, serving as a hub for regional distribution.

6. Hospital Groups: Large healthcare systems that import directly to meet the needs of their facilities. While not explicitly identified among the top buyers, such entities typically procure medications to ensure a steady supply for patient care.

Each segment exhibits distinct purchasing behaviors. Distributors and contract manufacturers often place large, periodic orders to maintain inventory levels and meet production schedules. Retail chains may order more frequently to replenish stock based on consumer demand. Government agencies typically procure through tender processes, resulting in bulk purchases aligned with budget cycles. Re-exporters' orders are influenced by the demands of their target markets, leading to variable order sizes and frequencies.

United States

1. Drug Regulatory Authority: U.S. Food and Drug Administration (FDA).

2. Import Registration Process: Importers must ensure that Levothyroxine is FDA-approved. The process involves submitting a New Drug Application (NDA) or an Abbreviated New Drug Application (ANDA) for generic products. Additionally, facilities involved in manufacturing, processing, or packaging must be registered with the FDA.

3. Estimated Timeline for Registration: The NDA process can take 6 to 10 months, while the ANDA process may take 10 months or more, depending on the complexity and completeness of the application.

4. Import Tariff/Duty for HS 30049099: Pharmaceutical products under HS code 30049099 are generally duty-free in the United States.

Peru

1. Drug Regulatory Authority: Dirección General de Medicamentos, Insumos y Drogas (DIGEMID).

2. Import Registration Process: Importers must obtain a Sanitary Registration from DIGEMID, which requires submission of technical documentation, including quality, safety, and efficacy data.

3. Estimated Timeline for Registration: The registration process typically takes 6 to 12 months, depending on the completeness of the application and any additional information requests.

4. Import Tariff/Duty for HS 30049099: Pharmaceutical products under this HS code are subject to a 6% import duty in Peru.

United Kingdom

1. Drug Regulatory Authority: Medicines and Healthcare products Regulatory Agency (MHRA).

2. Import Registration Process: Importers must hold a Wholesale Dealer's License (WDA(H)) and ensure that the product has a Marketing Authorization (MA) granted by the MHRA.

3. Estimated Timeline for Registration: Obtaining a WDA(H) can take up to 90 days, while the MA process may take 210 days, subject to the submission of a complete dossier.

4. Import Tariff/Duty for HS 30049099: Pharmaceutical products under this HS code are generally duty-free in the United Kingdom.

Australia

1. Drug Regulatory Authority: Therapeutic Goods Administration (TGA).

2. Import Registration Process: Importers must register Levothyroxine in the Australian Register of Therapeutic Goods (ARTG), requiring submission of comprehensive data on quality, safety, and efficacy.

3. Estimated Timeline for Registration: The registration process can take 12 to 18 months, depending on the complexity of the application and any additional information required.

4. Import Tariff/Duty for HS 30049099: Pharmaceutical products under this HS code are generally duty-free in Australia.

Chile

1. Drug Regulatory Authority: Instituto de Salud Pública de Chile (ISP).

2. Import Registration Process: Importers must obtain a Sanitary Registration from ISP, involving the submission of technical documentation and compliance with Good Manufacturing Practices (GMP).

3. Estimated Timeline for Registration: The registration process typically takes 12 to 24 months, depending on the completeness of the application and any additional information requests.

4. Import Tariff/Duty for HS 30049099: Pharmaceutical products under this HS code are subject to a 6% import duty in Chile.

The demand for Levothyroxine in importing countries is primarily driven by the prevalence of thyroid disorders, particularly hypothyroidism, which necessitates lifelong hormone replacement therapy. For example, in the United States, the American Thyroid Association estimates that approximately 20 million Americans have some form of thyroid disease, with up to 60% unaware of their condition. This high prevalence underscores the consistent demand for Levothyroxine.

Government healthcare programs and the expansion of universal health coverage also significantly influence demand. Many countries include Levothyroxine in their national Essential Medicines Lists, aligning with the World Health Organization's Model List of Essential Medicines, which recommends Levothyroxine for the treatment of hypothyroidism. This inclusion facilitates procurement through tender-based purchasing, ensuring availability in public health facilities. Additionally, international organizations like the United Nations Population Fund (UNFPA) support the procurement of essential medicines, including Levothyroxine, to improve access in low- and middle-income countries.

The presence of 235 buyers across 71 countries, as per TransData Nexus data, indicates a broad and sustained market opportunity for Levothyroxine. The repeat buyer rate of 66.4% further suggests stable and ongoing demand, highlighting the importance of maintaining robust supply chains and compliance with diverse regulatory requirements to capitalize on this market potential.

The 235 buyers of Levothyroxine from India can be categorized into several segments:

1. Distributors: Entities that purchase Levothyroxine in bulk to supply to various healthcare providers. For instance, EVERSANA LIFE SCIENCES SERVICES, LLC in the United States, with total imports amounting to $8.93 million, operates as a distributor, facilitating the distribution of pharmaceuticals across multiple channels.

2. Contract Manufacturers: Companies that import Levothyroxine as an active pharmaceutical ingredient (API) for formulation and packaging. WOCKHARDT UK LIMITED in the United Kingdom, importing $5.92 million worth of Levothyroxine, exemplifies this segment, utilizing the API for their pharmaceutical products.

3. Retail Chains: Large pharmacy chains that import Levothyroxine to stock their outlets. MACLEODS PHARMA USA, INC, the top importer with $21.62 million in imports, likely distributes the medication through its extensive retail network.

4. Government Procurement Agencies: Organizations responsible for acquiring medications for public health programs. While specific agencies are not listed among the top buyers, countries like Peru and Chile, with significant import values, may involve government tenders in their procurement processes.

5. Re-exporters: Companies that import Levothyroxine for the purpose of exporting to other markets. ALEMBIC PHARMACEUTICALS SPA in Chile, with imports totaling $1.65 million, may engage in such activities, serving as a hub for regional distribution.

6. Hospital Groups: Large healthcare systems that import directly to meet the needs of their facilities. While not explicitly identified among the top buyers, such entities typically procure medications to ensure a steady supply for patient care.

Each segment exhibits distinct purchasing behaviors. Distributors and contract manufacturers often place large, periodic orders to maintain inventory levels and meet production schedules. Retail chains may order more frequently to replenish stock based on consumer demand. Government agencies typically procure through tender processes, resulting in bulk purchases aligned with budget cycles. Re-exporters' orders are influenced by the demands of their target markets, leading to variable order sizes and frequencies.

United States

1. Drug Regulatory Authority: U.S. Food and Drug Administration (FDA).

2. Import Registration Process: Importers must ensure that Levothyroxine is FDA-approved. The process involves submitting a New Drug Application (NDA) or an Abbreviated New Drug Application (ANDA) for generic products. Additionally, facilities involved in manufacturing, processing, or packaging must be registered with the FDA.

3. Estimated Timeline for Registration: The NDA process can take 6 to 10 months, while the ANDA process may take 10 months or more, depending on the complexity and completeness of the application.

4. Import Tariff/Duty for HS 30049099: Pharmaceutical products under HS code 30049099 are generally duty-free in the United States.

Peru

1. Drug Regulatory Authority: Dirección General de Medicamentos, Insumos y Drogas (DIGEMID).

2. Import Registration Process: Importers must obtain a Sanitary Registration from DIGEMID, which requires submission of technical documentation, including quality, safety, and efficacy data.

3. Estimated Timeline for Registration: The registration process typically takes 6 to 12 months, depending on the completeness of the application and any additional information requests.

4. Import Tariff/Duty for HS 30049099: Pharmaceutical products under this HS code are subject to a 6% import duty in Peru.

United Kingdom

1. Drug Regulatory Authority: Medicines and Healthcare products Regulatory Agency (MHRA).

2. Import Registration Process: Importers must hold a Wholesale Dealer's License (WDA(H)) and ensure that the product has a Marketing Authorization (MA) granted by the MHRA.

3. Estimated Timeline for Registration: Obtaining a WDA(H) can take up to 90 days, while the MA process may take 210 days, subject to the submission of a complete dossier.

4. Import Tariff/Duty for HS 30049099: Pharmaceutical products under this HS code are generally duty-free in the United Kingdom.

Australia

1. Drug Regulatory Authority: Therapeutic Goods Administration (TGA).

2. Import Registration Process: Importers must register Levothyroxine in the Australian Register of Therapeutic Goods (ARTG), requiring submission of comprehensive data on quality, safety, and efficacy.

3. Estimated Timeline for Registration: The registration process can take 12 to 18 months, depending on the complexity of the application and any additional information required.

4. Import Tariff/Duty for HS 30049099: Pharmaceutical products under this HS code are generally duty-free in Australia.

Chile

1. Drug Regulatory Authority: Instituto de Salud Pública de Chile (ISP).

2. Import Registration Process: Importers must obtain a Sanitary Registration from ISP, involving the submission of technical documentation and compliance with Good Manufacturing Practices (GMP).

3. Estimated Timeline for Registration: The registration process typically takes 12 to 24 months, depending on the completeness of the application and any additional information requests.

4. Import Tariff/Duty for HS 30049099: Pharmaceutical products under this HS code are subject to a 6% import duty in Chile.

The demand for Levothyroxine in importing countries is primarily driven by the prevalence of thyroid disorders, particularly hypothyroidism, which necessitates lifelong hormone replacement therapy. For example, in the United States, the American Thyroid Association estimates that approximately 20 million Americans have some form of thyroid disease, with up to 60% unaware of their condition. This high prevalence underscores the consistent demand for Levothyroxine.

Government healthcare programs and the expansion of universal health coverage also significantly influence demand. Many countries include Levothyroxine in their national Essential Medicines Lists, aligning with the World Health Organization's Model List of Essential Medicines, which recommends Levothyroxine for the treatment of hypothyroidism. This inclusion facilitates procurement through tender-based purchasing, ensuring availability in public health facilities. Additionally, international organizations like the United Nations Population Fund (UNFPA) support the procurement of essential medicines, including Levothyroxine, to improve access in low- and middle-income countries.

The presence of 235 buyers across 71 countries, as per TransData Nexus data, indicates a broad and sustained market opportunity for Levothyroxine. The repeat buyer rate of 66.4% further suggests stable and ongoing demand, highlighting the importance of maintaining robust supply chains and compliance with diverse regulatory requirements to capitalize on this market potential.